Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
about
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial.C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow CrossmatchFrom Humoral Theory to Performant Risk Stratification in Kidney Transplantation.Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypesTorque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.Application, technical issues, and interpretation of C1q for graft outcome.C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes.A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.Antibody-mediated rejection: New approaches in prevention and management.The Spectrum of Histopathological Changes in the Renal Allograft - a 12 Months Protocol Biopsy Study.
P2860
Q30491939-8B62EADE-86FF-4FCD-A032-0871AAB9DBF7Q37263143-6EFF039F-1268-4051-A1A6-CF3CD61BA22CQ37590820-80405DB2-A118-440C-B090-2919257E73C0Q37611251-4984BF99-BFDD-41E4-9152-C0A79E2AA61FQ38725625-F2F79C80-7032-445B-B8BC-9DB3DED604C9Q38831291-3447CF69-A0C3-45CA-A0FE-CADDA41D08C7Q39445381-5853C976-5ADB-412F-91A6-CADFD232A157Q40417954-743AA427-0E4C-42E4-AB7B-5B7A452F3D72Q42670153-7F544A4E-F230-47BD-951C-D37A6AC1789DQ47292306-07DA1B03-543D-41AA-B1F8-A30CF35E2AF9Q47694251-32A8EF8C-4CB4-4B9E-A7C1-B9A4C5C674AEQ52401610-B03FA888-8A25-41C7-B583-01AA369410C0Q53825191-2760C93E-DD8C-45FA-8C1E-78AA536C9E52
P2860
Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Diagnostic Contribution of Don ...... oss-Sectional Screening Study.
@en
type
label
Diagnostic Contribution of Don ...... oss-Sectional Screening Study.
@en
prefLabel
Diagnostic Contribution of Don ...... oss-Sectional Screening Study.
@en
P2093
P50
P1433
P1476
Diagnostic Contribution of Don ...... ross-Sectional Screening Study
@en
P2093
Georg A Böhmig
Heinz Regele
Helmuth Haslacher
Lena Marinova
Luis G Hidalgo
Philip F Halloran
Rainer Oberbauer
Susanne Rasoul-Rockenschaub
Željko Kikić
P304
P356
10.1097/TP.0000000000001195
P50
P577
2017-03-01T00:00:00Z